BHST
BioHarvest Sciences Inc. (BHST) ESG Analysis Analysis (2026)
No material changes this month.
Environmental
BHST's R&D intensity of 16.3% of revenue suggests a comparatively innovation-oriented footprint, but peer-relative environmental benefits cannot be confirmed from the provided data alone.
Negative net debt to EBITDA indicates balance-sheet flexibility, which can support funding for efficiency initiatives, yet it is not direct evidence of superior environmental performance versus peers.
The absence of disclosed emissions, energy, water, or waste metrics limits assessment of operational environmental management, leaving BHST less transparent than peers with fuller reporting.
No Tier 1 filing evidence was provided for environmental targets or compliance outcomes, so relative positioning remains constrained by disclosure rather than demonstrated disadvantage.
Social
BHST's low stock-based compensation at 0.4% of revenue suggests restrained equity dilution, but it does not by itself indicate stronger employee alignment than peers.
High gross margin of 59.0% can support workforce investment and service quality, yet the metric is only indirectly related to social performance versus peers.
No data were provided on safety, turnover, diversity, training, or customer outcomes, which weakens confidence that BHST is socially differentiated from peers.
The limited social disclosure profile makes peer comparison difficult, and the available metrics do not show a clear structural social advantage or weakness.
Governance
BHST's debt-to-equity ratio of 0.89 suggests moderate leverage, which is generally more conservative than highly levered peers and supports governance discipline.
Negative net debt to EBITDA indicates net cash-like positioning, reducing refinancing pressure and lowering governance risk relative to peers with heavier debt burdens.
Low stock-based compensation at 0.4% of revenue points to limited dilution risk, which is typically viewed more favorably than peer practices with heavier equity issuance.
The lack of filing-based disclosure on board structure, audit oversight, and shareholder rights limits a higher score, despite the favorable capital-structure signals.
Overall Score
BHST appears moderately positioned versus peers, with the strongest relative signal coming from disciplined capital structure and limited dilution, offset by sparse ESG disclosure.
Score Driver: Moderately Favorable Governance Profile Driven By Low Leverage And Minimal Stock-Based Compensation.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on BioHarvest Sciences Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.
